EMA — authorised 14 March 2011
- Marketing authorisation holder: Nordic Group BV
- Status: approved
EMA authorised Gimestat on 14 March 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 14 March 2011.
Nordic Group BV holds the EU marketing authorisation.